PT - JOURNAL ARTICLE AU - Nakito, Prossy AU - Kisakye, Angela N. AU - Walekhwa, Abel Wilson AU - Tumukunde, Gloria AU - Mutesi, Charity AU - Muhumuza, Nicholas AU - Nyamor, Carolyne AU - Musoke, David AU - Musinguzi, Geofrey AU - Byonanebye, Dathan M. TI - Prevalence and predictors of self-medication for COVID-19 among slum dwellers in Jinja City, Uganda AID - 10.1101/2023.09.08.23295267 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.08.23295267 4099 - http://medrxiv.org/content/early/2023/09/09/2023.09.08.23295267.short 4100 - http://medrxiv.org/content/early/2023/09/09/2023.09.08.23295267.full AB - Introduction Self-medication is a serious public health concern globally and is more prevalent in underserved populations, especially in resource limited settings. The lack of effective treatment for COVID-19 and poor access to healthcare were drivers of self-medication. We investigated the prevalence and associated factors with self-medication for COVID-19 among slum dwellers in a Ugandan slum.Methods and materials We conducted a cross-sectional study using randomly selected respondents from slums in Jinja city, Uganda. Households were proportionately selected from the slums and one participant with confirmed or self-reported COVID-19 during 2021 was recruited. Poisson regression with robust standard errors was used to determine the crude (CPR) and adjusted prevalence ratios (APR) (95% CI) of factors associated with self-medication. Variables were selected apriori and backward elimination approach used to fit the final multivariate model in which variables with a P≤ 0.05 were included.Results Overall, 517 respondents were recruited, median age (years) was 31 (26-40), and 59% were male. The prevalence of self-medication for COVID-19 was 87.23% (451/517), 95% CI: [84.00%-90.00%] and 56% knew that self-medication was dangerous. Age≥50 years, compared to 20-29 years [APR: 1.12, 95% CI:1.05, 1.20], being female [APR: 1.07, 95% CI: 1.02, 1.13], minor [APR: 1.62, 95% CI: 1.25, 2.11], and severe symptoms [APR: 1.51, 95% CI: 1.16, 1.96], access to internet [APR: 1.13, 95% CI: 1.07, 1.20]. Having medical insurance [APR: 0.63, 95% CI: 0.46, 0.87] and awareness about laws against self-medication [APR: 0.89, 95% CI: 0.81, 0.97] were associated with a lower risk of self-medication.Conclusion The prevalence of self-medication in slum dwellers in Uganda was high despite high awareness about its dangers. Self-medication was common in those with severe symptoms and those access to internet. There is need to control infodemia and improve health insurance cover in informal settlements within Uganda.Competing Interest StatementThe authors have declared that no competing interests exist.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We obtained ethical approval to conduct this study from Makerere University, School of Public Health Higher Degrees Research and Ethics Committee (HDREC), approval number FWA00011353.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData Access / Ethics Committee (contact via email:prossynakito{at}gmail.com) for researchers who meet the criteria for access to confidential data.